文献速递瓣膜外科

重度主动脉瓣狭窄合并重度二尖瓣反流中二尖瓣钙化对左心重构、手术策略及结局的影响

Effects of mitral calcification in severe aortic stenosis with severe mitral regurgitation on left heart remodeling, surgical strategy, and outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-10-21

本研究纳入158例重度主动脉瓣狭窄、重度二尖瓣反流合并二尖瓣钙化患者,术前CT定位并量化二尖瓣钙化,分析其与心脏重构、手术方式及长期生存的关系。结果显示钙化体积越大越倾向于行二尖瓣置换,且与晚期心脏重构相关,但多因素分析显示晚期死亡率与钙化体积或位置无关。

要点

  • 二尖瓣钙化体积越大,越可能需行主动脉瓣置换联合二尖瓣置换。
  • 二尖瓣钙化体积与晚期心脏重构相关,但不预测远期死亡。
  • 瓣下钙化与早期术后死亡强相关,术前CT量化钙化有助决策。

核心结论

  • 二尖瓣钙化体积较大是晚期心脏重构的标志,与更广泛二尖瓣干预相关,但与长期死亡率无关。

研究设计与样本

  • 回顾性单中心队列研究,1998年7月至2010年7月纳入158例重度主动脉瓣狭窄、重度二尖瓣反流合并二尖瓣钙化患者。
  • 患者接受单纯主动脉瓣置换(SAVR,n=49)、SAVR联合二尖瓣修复(SAVR+MVr,n=67)或SAVR联合二尖瓣置换(SAVR+MVR,n=42)。
  • 术前CT定位并量化二尖瓣钙化,采用随机森林方法分析钙化体积与心脏形态功能的关系;生存随访中位4.1年,25%患者随访≥14年。

主要发现

  • 钙化体积较大与退行性二尖瓣病变、较高射血分数、较小左室收缩末期容积及SAVR+MVR相关。
  • SAVR+MVR组中位钙化体积为3.4 cm3,SAVR组为1.0 cm3,SAVR+MVr组为0.41 cm3。
  • 十年死亡率随钙化体积三分位升高而增加(7.1% vs 16% vs 25%),瓣下受累者亦较高(8.1% vs 18%)。
  • 十年死亡率SAVR+MVR组为5.4%(对比SAVR),SAVR+MVr组为13%(对比SAVR+MVR为26%)。
  • 多因素分析显示早期术后死亡与瓣下二尖瓣钙化强相关,但晚期死亡与钙化体积或位置无关。

关键数值与推荐

  • 二尖瓣钙化体积三分位对应十年死亡率分别为7.1%、16%、25%。
  • 瓣下二尖瓣钙化受累者十年死亡率为18%,无受累者为8.1%。
  • SAVR+MVR组十年死亡率为5.4%(对比SAVR),SAVR+MVr组为13%(对比SAVR+MVR为26%)。

临床怎么用

  • 术前CT量化二尖瓣钙化体积可辅助筛选患者和制定手术策略。
  • 钙化体积较大者更可能需要二尖瓣置换,应预判复杂手术。
  • 瓣下钙化提示早期术后死亡风险较高,需加强围术期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To localize and quantify mitral calcification associated with severe aortic stenosis and severe mitral regurgitation and determine its association with cardiac remodeling, operative management, and long-term survival. METHODS: Between July 1998 and July 2010, 158 patients with severe aortic stenosis, severe mitral regurgitation, and mitral calcification underwent surgical aortic valve replacement (SAVR; n = 49) or SAVR plus mitral valve repair (SAVR+MVr; n = 67) or replacement (SAVR+MVR; n = 42) at our institution. Mitral calcium was localized and quantified by a preoperative computed tomography (CT) scan. Random forest methodology was used to correlate calcium volume with cardiac morphology and function. The median follow-up for survival was 4.1 years; 25% of patients were followed for ≥14 years. RESULTS: Greater calcium volume was associated with degenerative mitral disease, higher ejection fraction, smaller left ventricular end-systolic volume, and SAVR+MVR (median calcium volume, 3.4 cm3) compared to SAVR (median calcium volume, 1.0 cm3) or SAVR+MVr (median calcium volume, 0.41 cm3). Ten-year mortality was higher in patients with more mitral calcification (terciles: 7.1% vs 16% vs 25%), subvalvular involvement (8.1% vs 18%), and SAVR+MVR (5.4% vs SAVR; 13% vs SAVR+MVr = 26%). Multivariable analysis showed that early postoperative mortality was strongly associated with subvalvular mitral calcification, but late mortality was not associated with calcium volume or location. CONCLUSIONS: Greater mitral calcium volume is a marker of late-stage cardiac remodeling associated with more extensive mitral valve intervention but not with long-term mortality. Quantitative analysis of mitral calcification with CT can aid patient selection and surgical management decisions in this complex patient population.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Snyder A, Isabella M, Rodriguez L, et al. Effects of mitral calcification in severe aortic stenosis with severe mitral regurgitation on left heart remodeling, surgical strategy, and outcomes. J Thorac Cardiovasc Surg. 2024. PMID: 39442864. doi:10.1016/j.jtcvs.2024.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。